发明名称 SKI 606 as src kinase inhibitor for treating osteolytic lesions
摘要 <p>The present invention include methods and compositions for treating bone-resorbing diseases or bone resorption related to a pathologic condition generally, including, but not limited to osteoporosis, arthritis, rheumatoid arthritis, cancer metastases to the bone, bone cancer, hypercalcemia, osteolytic lesions with orthopedic implants, Paget's disease, and bone loss associated with hyperparathyroidism. Representative cancers include, but are not limited to breast cancer, prostrate cancer, colon cancer, endometrial cancer, multiple myeloma, renal cell carcinoma, heck and neck cancers, and cervical carcinoma. Arthritic conditions include, but are not limited to adjuvant-, collagen-, bacterial- and antigen-induced arthritis, particularly rheumatoid arthritis.</p>
申请公布号 SI1896020(T1) 申请公布日期 2014.11.28
申请号 SI20060031836T 申请日期 2006.06.16
申请人 THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 发明人 DARNAY BRYANT G.;PRICE JANET E.;POBLENZ ANN;TALPAZ MOSHE
分类号 主分类号
代理机构 代理人
主权项
地址